Article Details

FDA Accepts Roche's Supplemental Biologics License Application for Gazyva/Gazyvaro in ...

Retrieved on: 2025-03-05 18:42:09

Tags for this article:

Click the tags to see associated articles and topics

FDA Accepts Roche's Supplemental Biologics License Application for Gazyva/Gazyvaro in .... View article details on hiswai:

Excerpt

The FDA has accepted Roche's supplemental Biologics License Application (sBLA) for Gazyva/Gazyvaro (obinutuzumab) for the treatment of lupus ...

Article found on: www.pharmexec.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo